Presenter: Neal Howard
Guest Bio: Carolyn Thompson is Board Chair for BioPharma Global. A graduate of Kansas State University, she is Founding Board Chair of the Washington Women’s Leadership Initiative (WWLI.org), a board member at The Girl Scout Council of the National Capital Area and My Sister’s Place in Washington, DC. As Principal of Merito Group, Carolyn leads a team of talent acquisition professionals providing client services to a wide range of industries including Big 4, Fortune 1000 companies and small business owners alike. A creative entrepreneur and a credentialed career coach, she is regularly published on topics relating to employment, careers, job search, business strategy, social media, organizational and professional development and executive recruiting in various national magazines, trade journals, and on the Internet. An alumnus of Kansas State University, Carolyn is the author of TEN EASY STEPS TO A PERFECT RESUME, TEN STEPS TO FINDING THE PERFECT JOB, and TEN SECRETS TO GETTING PROMOTED.
James LaFlamme has more than 30 years of healthcare operational experience and has held a variety of senior positions including CEO, Chief Operations Officer, Vice President of Clinical Services, and Administrative Director at several hospitals and health systems. In his current role as Chief Executive Officer he is responsible for leading global operations for BioPharma Global. This encompasses overseeing the development and delivery of all advisory opinions and client deliverables as well as a full complement of Client Development activities on a worldwide basis. James earned a BS degree in Pharmacy from the University of Connecticut School of Pharmacy and a MS degree in Management from Indiana Wesleyan University. He serves on the Deans Advisory Board at the UCONN School of Pharmacy and is a Fellow of the American College of Healthcare Executives.
Segment overview: Carolyn Thompson, Board Chair, and James LaFlamme, President & CEO of BioPharma Global discuss rare diseases, the trends in rare disease research, and the FDA and EMA approval processes.
Transcript – TBU